Thursday, Apr 25 2024 | Time 21:12 Hrs(IST)
image
Business Economy


Alembic Pharmaceuticals gets USFDA approval for Desvenlafaxine Extended Release Tablets, 25 mg

Mumbai, Sep 17 (UNI) Pharma Major, Alembic Pharmaceuticals Limited on Monday said that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Des enlafaxine Extended-Release Tablets, 25 mg.
The approved ANDA is therapeuticall equivalent to the reference listed drug product (RLD), PRISTIQ ExtendedRelease Tabl ts, 25 mg of Wyeth Pharma Inc. Desvenlafaxine Extended-Release Tablets, 25 mg are
indica ed for the treatment of major depressive disorder (MOD), the company said in a filing with BSE.
Desvenlafaxine Extended-Release Tablets, 25 mg has an estimated market size of USD 13.3 million for twelve months ending December 2017, according to IQVIA.
Alembic now has a total of 77 ANDA approvals (64 final approvals and 13 tentative approvals) from USFDA.
UNI JS SB 1523
More News

Tech Mahindra net at Rs 661 crore in Q4; Company gives dividend of Rs 28 per share

25 Apr 2024 | 7:28 PM

New Delhi, April 25 (UNI) Mahindra Group company Tech Mahindra, a technology consulting and digital solutions provider, on Thursday reported about 41 per cent decline in net profit at Rs 661 crore year-on-year basis for the fourth quarter ended March 31, 2024.

see more..

Kottayam-Kochi Rubber Market Rates

25 Apr 2024 | 7:26 PM

Kottayam, April 25 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..
Indusind Bank net up 15 pc in Q4

Indusind Bank net up 15 pc in Q4

25 Apr 2024 | 7:10 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported a 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023–24, compared to Rs 2,043 crore in the same quarter in 2022–23.

see more..

25 Apr 2024 | 6:53 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023-24 compared to Rs 2,043 crore in the same quarter in 2022-23.

see more..

Regulations to become more stringent, demanding in coming years : CUB MD

25 Apr 2024 | 6:40 PM

Chennai, Apr 25 (UNI) “Regulations are going to be here, and they are going to
get more stringent as there is a learning depending upon the changes in the
environment and the role of the CFO's,” City Union Bank (CUB) MD and CEO
Dr N Kamakodi observed on Thursday.

see more..
image